Infectious Disease Surveillance in the 21st Century: An Integrated Web-Based Surveillance and Case Management System

Troppy, Scott; Haney, Gillian; Cocoros, Noelle M; Cranston, Kevin; DeMaria, Alfred

doi:10.1177/003335491412900206

Cited by 41 publications

(44 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are many reasons for the inefficient exchange of data within states and between states and CDC including categorically funded systems, disparate data collection processes, lack of interoperability and standards to support data exchange and use, shortage of technology savvy public health workers, data sharing policies, and others. 8 …”

Section: Discussionmentioning

confidence: 99%

An Assessment of Information Exchange Practices, Challenges, and Opportunities to Support US Disease Surveillance in 3 States

García

Garrett²,

Singletary

et al. 2018

Journal of Public Health Management and Practice

Self Cite

View full text Add to dashboard Cite

State and local public health agencies collect and use surveillance data to identify outbreaks, track cases, investigate causes, and implement measures to protect the public’s health. We sought to better understand current practices at state and local public health agencies for collecting, managing, processing, reporting, and exchanging notifiable disease surveillance information. Over an 18-month period (January 2014-June 2015), we evaluated the process of data exchange between surveillance systems, reporting burdens, and challenges within three states (California, Idaho, and Massachusetts) that were using three different reporting systems. All three states use a combination of paper-based and electronic information systems for managing and exchanging data on reportable conditions within the state. The flow of data from local jurisdictions to the state health departments varies considerably. When state and local information systems are not interoperable, manual duplicative data entry and other workarounds are often required. The results of the assessment show the complexity of disease reporting at the state and local levels and the multiple systems, processes, and resources engaged in preparing, processing, and transmitting data that limit interoperability and decrease efficiency. Despite ongoing challenges, considerable progress has been made in implementation of electronic systems and as a result, efficiency has improved substantially in the last decade.

show abstract

Section: Discussionmentioning

confidence: 99%

An Assessment of Information Exchange Practices, Challenges, and Opportunities to Support US Disease Surveillance in 3 States

García

Garrett²,

Singletary

et al. 2018

Journal of Public Health Management and Practice

Self Cite

View full text Add to dashboard Cite

show abstract

“…Reporting of infectious diseases is conducted under state authority in the United States. In Massachusetts, electronic laboratory results are transmitted using standard codes to the Web‐based surveillance and case management system, the Massachusetts Virtual Epidemiologic Network (MAVEN), described in greater detail elsewhere . Records in MAVEN are patient based; therefore, a new laboratory result is appended to an existing patient record, or MAVEN creates a new disease “event.” When a new suspected babesiosis case is identified, an investigation is triggered and the state and local DPH are notified.…”

Section: Methodsmentioning

confidence: 99%

Transfusion‐transmitted babesiosis: one state's experience

et al. 2018

Self Cite

View full text Add to dashboard Cite

BACKGROUND The risk for tickborne exposure to Babesia microti infection exists statewide in Massachusetts. Broad exposure complicates investigations of transfusion‐transmitted babesiosis (TTB). We summarize 8 years of the epidemiology of TTB and highlight the role of public health in prevention and control. STUDY DESIGN AND METHODS Cases of babesiosis are routinely reported to the Massachusetts Department of Public Health. These are investigated to determine whether they meet the surveillance case definition and to identify whether they were potentially transfusion transmitted. Frequencies from 2009 to 2016 are described and incidence rates calculated using population denominators from the US census. Changes over time were analyzed using simple linear regression. RESULTS From 2009 to 2016, there were 2578 cases of babesiosis reported; of these, 45 (1.7%) were transfusion transmitted. Of the 45 cases of TTB, 15 (33%) received blood products from two or more suppliers. In 11 TTB cases, the Department of Public Health was notified first, who in turn notified the appropriate blood provider. In 2009, the crude rate of reported babesiosis was 1.2 per 100,000 population and increased significantly through 2016 to 7.8 per 100,000 population (p = 0.006). The number of blood donors reported with laboratory evidence of B. microti infection increased from 19 in 2012 to 78 in 2016; at the same time, the number of TTB cases decreased from six to three. CONCLUSION TTB remains a major challenge, and blood donor screening strategies are currently in the process of implementation. While population and environmental changes facilitate increases in babesiosis, donor screening has the potential to eliminate TTB.

show abstract

“…Data were extracted from the Massachusetts Virtual Epidemiologic Network (MAVEN), which is the MDPH’s web-based surveillance and case management system (14). MAVEN includes demographic and clinical data derived from health screenings overseas and shortly after arrival in Massachusetts.…”

Section: Methodsmentioning

confidence: 99%

Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011–2013

et al. 2017

View full text Add to dashboard Cite

IntroductionThe receipt rate of hepatitis B virus vaccine among adolescents in the United States is high, while the receipt rate of human papillomavirus vaccine is low. Rates have not been closely studied among refugees, whose home countries have high rates of disease caused by these viruses.MethodsWe examined human papillomavirus and hepatitis B virus immunization rates among 2,269 refugees aged 9 to 26 years who resettled in Massachusetts from 2011 through 2013. This was a secondary analysis of data from their medical screenings. We used binary logistic regression to assess characteristics associated with immunization and bivariate analyses to compare refugee immunization rates with those of the general US population.ResultsForty-five percent of US adolescents aged 13 to 17 years received 1 dose of human papillomavirus vaccine, compared with 68% of similarly aged refugees. Males (adjusted odds ratio [aOR], 0.62; 95% confidence interval [CI], 0.52–0.74), refugees older than 13 years (aOR, 0.74; 95% CI, 0.60–0.93), and refugees not from Sub-Saharan Africa (aOR, 0.74; 95% CI, 0.59–0.92) were less likely to receive human papillomavirus vaccine, while arrivals in 2012 through 2013 were more likely (aOR, 1.6; 95% CI, 1.3–1.9) than those arriving in 2011. Refugees older than 13 years were less likely to receive 2 doses of hepatitis B virus vaccine (aOR, 0.49; 95% CI, 0.37–0.63) than older refugees.ConclusionSpecialized post-arrival health assessment may improve refugees’ immunization rates.

show abstract

Infectious Disease Surveillance in the 21st Century: An Integrated Web-Based Surveillance and Case Management System

Cited by 41 publications

References 4 publications

An Assessment of Information Exchange Practices, Challenges, and Opportunities to Support US Disease Surveillance in 3 States

An Assessment of Information Exchange Practices, Challenges, and Opportunities to Support US Disease Surveillance in 3 States

Transfusion‐transmitted babesiosis: one state's experience

Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011–2013

Contact Info

Product

Resources

About